中文/English

Clinical Trial

[Subject recruitment] A open-label, dose-escalation Phase I trial of PA3-17 injection in adult patients with CD7-positive relapsed/refractory lymphoid hematologic malignancies
Clinical Trial 2373 Views 2022-03-07 10:43

Unique Protocol ID: PG-CART-007-001
Brief Title: CD7 CAR-T Cells for Patients With R/R CD7+ NK/T Cell Lymphoma,T- lymphoblastic Lymphoma and Acute Lymphocytic Leukemia
Official Title: CD7 CAR-T Cells for Patients With Relapse/Refractory CD7+ NK/T Cell Lymphoma ,T-lymphoblastic Lymphoma and Acute Lymphocytic Leukemia
Clinical Trial 3570 Views 2020-04-27 13:44